Total Payments
$1,830
2024 Payments
$192.53
Companies
24
Transactions
111
Medicare Patients
7,506
Medicare Billing
$593,336
Payment Breakdown by Category
Food & Beverage$1,533 (83.8%)
Education$296.95 (16.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,533 | 107 | 83.8% |
| Education | $296.95 | 4 | 16.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $231.07 | 12 | $0 (2023) |
| Terumo Medical Corporation | $210.00 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $199.98 | 2 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $161.31 | 31 | $0 (2022) |
| Amgen Inc. | $158.75 | 10 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $120.91 | 6 | $0 (2024) |
| ABIOMED | $106.50 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.49 | 6 | $0 (2018) |
| Allergan Inc. | $76.24 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $62.47 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.53 | 8 | Novartis Pharmaceuticals Corporation ($84.47) |
| 2023 | $50.39 | 3 | ABIOMED ($31.44) |
| 2022 | $59.80 | 3 | Abbott Laboratories ($47.42) |
| 2021 | $99.25 | 5 | Abbott Laboratories ($99.25) |
| 2020 | $243.31 | 3 | Astellas Pharma US Inc ($199.98) |
| 2019 | $56.09 | 1 | LivaNova USA, Inc. ($56.09) |
| 2018 | $548.94 | 27 | Terumo Medical Corporation ($210.00) |
| 2017 | $579.91 | 61 | Janssen Pharmaceuticals, Inc ($135.22) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $49.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/27/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Lithoplasty | ||||||
| 08/25/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.67 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/16/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $31.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/23/2023 | Abbott Laboratories | XIENCE SIERRA (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Vascular | ||||||
| 10/20/2022 | Abbott Laboratories | JETI ALL IN ONE NON-STERILE KIT (Device) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Vascular | ||||||
| 09/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2022 | Abbott Laboratories | OMNILINK ELITE (Device) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Vascular | ||||||
| 11/26/2021 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Vascular | ||||||
| 09/30/2021 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Vascular | ||||||
| 09/09/2021 | Abbott Laboratories | Xience Sierra Coronary Stent (Device) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Vascular | ||||||
| 04/16/2021 | Abbott Laboratories | Hi-Torque Pilot guide wire (Device) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Vascular | ||||||
| 04/01/2021 | Abbott Laboratories | Optis Coronary Imaging System (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Vascular | ||||||
| 10/14/2020 | Inari Medical, Inc. | FlowTriever (Device), ClotTriever | Food and Beverage | In-kind items and services | $43.33 | General |
| Category: Venous Thrombectomy | ||||||
| 04/16/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 04/16/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/13/2019 | LivaNova USA, Inc. | TandemLife (Device) | Food and Beverage | In-kind items and services | $56.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/21/2018 | Cardiovascular Systems Inc. | Coronary Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $9.73 | General |
| Category: Atherectomy Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,031 | 2,712 | $618,320 | $156,676 |
| 2022 | 22 | 2,052 | 2,546 | $583,160 | $152,986 |
| 2021 | 21 | 1,679 | 2,264 | $515,195 | $139,361 |
| 2020 | 24 | 1,744 | 2,296 | $582,333 | $144,314 |
Total Patients
7,506
Total Services
9,818
Medicare Billing
$593,336
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 412 | 526 | $143,598 | $45,019 | 31.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 49 | 63 | $99,918 | $22,947 | 23.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 156 | 157 | $93,218 | $19,995 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 262 | $48,470 | $13,068 | 27.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 67 | 69 | $54,924 | $10,327 | 18.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 126 | $23,184 | $7,419 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $21,684 | $5,375 | 24.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 462 | 508 | $23,368 | $4,690 | 20.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 87 | 87 | $15,138 | $4,488 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $14,268 | $3,959 | 27.7% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $14,126 | $3,422 | 24.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $11,550 | $2,912 | 25.2% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 20 | 355 | $11,715 | $2,636 | 22.5% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $14,432 | $2,398 | 16.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 11 | 44 | $2,900 | $1,716 | 59.2% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 13 | 26 | $1,846 | $924.72 | 50.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 95 | 99 | $2,871 | $890.23 | 31.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 41 | 55 | $3,905 | $868.04 | 22.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $3,354 | $794.69 | 23.7% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 14 | 14 | $3,584 | $716.80 | 20.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 21 | 30 | $2,760 | $640.37 | 23.2% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 13 | 17 | $3,094 | $465.46 | 15.0% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 17 | 17 | $1,819 | $384.34 | 21.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 55 | 62 | $1,574 | $348.84 | 22.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 17 | 17 | $1,020 | $270.81 | 26.6% |
About Dr. Peter Sharis, M.D
Dr. Peter Sharis, M.D is a Cardiovascular Disease healthcare provider based in Davenport, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275512154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Sharis, M.D has received a total of $1,830 in payments from pharmaceutical and medical device companies, with $192.53 received in 2024. These payments were reported across 111 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,533).
As a Medicare-enrolled provider, Sharis has provided services to 7,506 Medicare beneficiaries, totaling 9,818 services with total Medicare billing of $593,336. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Davenport, IA
- Active Since 01/10/2006
- Last Updated 08/19/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275512154
Products in Payments
- Optitorque (Device) $210.00
- XARELTO (Drug) $161.31
- Corlanor (Drug) $158.75
- Impella (Device) $106.50
- PRADAXA (Drug) $81.49
- ELIQUIS (Drug) $80.75
- ENTRESTO (Drug) $70.00
- Xience Sierra Coronary Stent (Device) $63.63
- BRILINTA (Drug) $62.47
- BYSTOLIC (Drug) $57.46
- TandemLife (Device) $56.09
- LifeVest (Device) $51.34
- LEQVIO (Drug) $50.91
- KENGREAL (Drug) $45.98
- CardioMEMS HF System (Device) $44.34
- FlowTriever (Device) $43.33
- Coronary Orbital Atherectomy System (Device) $25.98
- JETI ALL IN ONE NON-STERILE KIT (Device) $24.02
- Xience V coronary stent system (Device) $23.78
- OMNILINK ELITE (Device) $23.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Davenport
Srikanth Kasula, M.d, M.D
Cardiovascular Disease — Payments: $57,415
Cardiovascular Disease $57,415
Gursukhman Deep Sidhu, Md, MD
Cardiovascular Disease — Payments: $54,094
Cardiovascular Disease $54,094
Dr. Claudio Manubens, M.d, M.D
Cardiovascular Disease — Payments: $21,622
Cardiovascular Disease $21,622
Prem Srinivas Subramaniyam, Md, MD
Cardiovascular Disease — Payments: $7,643
Cardiovascular Disease $7,643
Dr. Jon Robken, M.d, M.D
Cardiovascular Disease — Payments: $5,896
Cardiovascular Disease $5,896
Motaz Moussa, Md, MD
Cardiovascular Disease — Payments: $4,963
Cardiovascular Disease $4,963